版本:
中国

BRIEF-Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101

June 14 Avexis Inc:

* Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101

* Avexis Inc - Avexis anticipates initiating U.S. SMA Type 1 and Type 2 trials in Q3 2017 with product from new process

* Says ‍avexis will continue to utilize HEK293 cells and an adherent cell line​

* Says ‍alignment includes support for proposed commercial manufacturing process​

* Says ‍commercial-scale GMP process will not include use of hyperstacks for AAV9 vector production​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐